Senti Biosciences Holdings, Inc. — Form 8-K
Filed September 24, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Senti Biosciences filed a Form 8-K on 2026-09-24 reporting Item 5.02 events: departure of director(s) or officer(s) and/or election of directors and appointment of officers, with compensatory arrangement modifications. The filing itself does not disclose specific names, dollar amounts, effective dates, or details of the compensation changes—only that such events occurred on or before 2026-09-23.
Why this rating
No material dollar amounts, names, or terms disclosed. Leadership/compensation changes are routine 8-K filings absent specifics suggesting material impact.
Extracted items
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.